BRPI0923645A2 - processo para preparar um composto derivado de quinazolina e forma cristalina de monoidrato. - Google Patents

processo para preparar um composto derivado de quinazolina e forma cristalina de monoidrato.

Info

Publication number
BRPI0923645A2
BRPI0923645A2 BRPI0923645A BRPI0923645A BRPI0923645A2 BR PI0923645 A2 BRPI0923645 A2 BR PI0923645A2 BR PI0923645 A BRPI0923645 A BR PI0923645A BR PI0923645 A BRPI0923645 A BR PI0923645A BR PI0923645 A2 BRPI0923645 A2 BR PI0923645A2
Authority
BR
Brazil
Prior art keywords
monohydrate
preparing
crystalline form
derivative compound
quinazoline derivative
Prior art date
Application number
BRPI0923645A
Other languages
English (en)
Inventor
Motoyuki Hagihara
Shoji Shinomoto
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of BRPI0923645A2 publication Critical patent/BRPI0923645A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0923645A 2008-12-25 2009-12-24 processo para preparar um composto derivado de quinazolina e forma cristalina de monoidrato. BRPI0923645A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008330600 2008-12-25
PCT/JP2009/071445 WO2010074150A1 (ja) 2008-12-25 2009-12-24 キナゾリン誘導体の製造方法

Publications (1)

Publication Number Publication Date
BRPI0923645A2 true BRPI0923645A2 (pt) 2016-08-02

Family

ID=42287757

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923645A BRPI0923645A2 (pt) 2008-12-25 2009-12-24 processo para preparar um composto derivado de quinazolina e forma cristalina de monoidrato.

Country Status (10)

Country Link
US (1) US8426589B2 (pt)
EP (1) EP2374801A4 (pt)
JP (1) JP5752420B2 (pt)
KR (1) KR101638645B1 (pt)
CN (1) CN102264708B (pt)
BR (1) BRPI0923645A2 (pt)
CA (1) CA2745150C (pt)
MX (1) MX2011006900A (pt)
TW (1) TWI466872B (pt)
WO (1) WO2010074150A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9951051B2 (en) 2014-05-29 2018-04-24 Shionogi & Co., Ltd. Process for producing alkynylketone derivative
CN105017162B (zh) * 2015-06-26 2017-10-27 陕西师范大学 4‑对丙烯基苯氨基喹唑啉衍生物及其在制备抗肿瘤药物中的应用
DK3330267T3 (da) * 2015-07-29 2022-03-14 Shionogi & Co Salt af quinazolinderivat eller crystal deraf samt fremgangsmåde til fremstilling af salt af quinazolinderivat eller crystal deraf
EP3574906A4 (en) 2017-01-30 2021-01-20 Shionogi & Co., Ltd. SOLID PREPARATION WITH CHINAZOLINE DERIVATIVE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2431843T3 (es) 2005-02-23 2013-11-28 Shionogi & Co., Ltd. Derivado de quinazolina que tiene actividad inhibidora de tirosina quinasa

Also Published As

Publication number Publication date
EP2374801A4 (en) 2012-08-15
WO2010074150A1 (ja) 2010-07-01
KR101638645B1 (ko) 2016-07-11
US20110257391A1 (en) 2011-10-20
MX2011006900A (es) 2011-07-20
US8426589B2 (en) 2013-04-23
CN102264708A (zh) 2011-11-30
JPWO2010074150A1 (ja) 2012-06-21
CA2745150A1 (en) 2010-07-01
TWI466872B (zh) 2015-01-01
TW201028387A (en) 2010-08-01
JP5752420B2 (ja) 2015-07-22
KR20110103438A (ko) 2011-09-20
CN102264708B (zh) 2015-02-25
CA2745150C (en) 2016-08-09
EP2374801A1 (en) 2011-10-12

Similar Documents

Publication Publication Date Title
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI0917196A2 (pt) método para a preparação de um complexo, e, forma cristalina de um composto.
BRPI0920356A2 (pt) Processo para a preparação de compostos úteis como inibidores de sglt
BRPI0816258A2 (pt) processo para a preparação de compostos úteis como inibidores de sglt
BRPI0909655A2 (pt) Processo para a preparação regioseletiva de derivados de ácido 1-alquil-3-haloalquil-pirazol-4carboxílico
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI1012018A2 (pt) processo para preparar um composto
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BRPI0810067A2 (pt) Processo para a preparação de capecitabina
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI0919241A8 (pt) processo para fabricação de compostos de quinolona
BRPI0921420A2 (pt) processo para preparar compostos
BRPI0814163A2 (pt) Processo para a preparação de compostos, forma cristalina, e, composição farmacêutica
BRPI0913989A2 (pt) processo para preparação de derivados de benzoimidazol-2-il pirirmidina
BRPI1011671A2 (pt) processo para produzir cristais de forma a de ácido 2-(3-ciano-4-isobutiloxifenil)-4metil-5-tiazolacarbocíclico
BRPI0811315A2 (pt) Processo para a preparação de um composto
BRPI1010571A2 (pt) processo para a preparação de um composto útil como um inibidor de tafla.
BR112012002130A2 (pt) processo para a preparação de composto,e, composto intermediário
BRPI0913644A2 (pt) processo para a prepração de derivados de pirimidina substituída.
BRPI0821752A2 (pt) Processo para preparar derivados de ácido 22-fluoracil-3-amino-acrílico
BRPI0914792A2 (pt) processo para a preparação de polióis
BRPI0910595A2 (pt) processo para a produção de composto de pirimidina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.